SCHEMBL23830652

SCHEMBL23830652

CC(C)(C)OC(=O)N1CC(=Cc2ccc3c(c2)NC(=O)C3(F)F)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.41
CRBN Q96SW2 3/20 0.41
DDB1 Q16531 2/20 0.41
ESR2 Q92731 1/20 0.36
NR1H2 P55055 4/20 0.35
MAPK1 P28482 1/20 0.35
PDK2 Q15119 1/20 0.34
GPR119 Q8TDV5 5/20 0.34
RXRA P19793 2/20 0.34
NR1H3 Q13133 2/20 0.34
CLK2 P49760 1/20 0.33
CLK3 P49761 1/20 0.33
GSK3B P49841 1/20 0.33
DYRK1A Q13627 1/20 0.33
DYRK2 Q92630 1/20 0.33
CLK4 Q9HAZ1 1/20 0.33
DYRK1B Q9Y463 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33
THRB P10828 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23830873 0.80 CRBN (0.48) HDAC1CRBNDDB1ESR2NR1H2
SCHEMBL23830447 0.76 TRPV1 (0.45) MAPT
SCHEMBL17296111 0.74 HDAC1 (0.45) HDAC1ESR2NR1H2MAPK1ACHE
SCHEMBL24357650 0.73 HDAC1 (0.46) HDAC1CRBNDDB1ESR2NR1H2
SCHEMBL23842691 0.72 IKBKB (0.34)
SCHEMBL31611716 0.72 HDAC1 (0.45) HDAC1ESR2NR1H2MAPK1GPR119
SCHEMBL26215454 0.72 MAPT (0.50) HDAC1ESR2GPR119MAPT
SCHEMBL17541997 0.71 NR1H2 (0.50) HDAC1ESR2NR1H2MAPK1GPR119
SCHEMBL17542019 0.71 HDAC1 (0.48) HDAC1ESR2NR1H2MAPK1
SCHEMBL24357767 0.71 HDAC1 (0.44) HDAC1ESR2NR1H2GPR119MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210292305-A1 Cyclic Ureas SIRONAX LTD (KY) 2021-09-23 US disclosed
CN-113302183-A Cyclic ureas 圣瑞诺有限公司 2021-08-24 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210292305-A1 Cyclic Ureas RIPK1, RIPK3, RIPK4 HDAC1 465/4885CRBN 2957/4885DDB1 881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.